Day: July 28, 2025
FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
Written by Customer Service on . Posted in Public Companies.
Regional Health Properties, Inc. Outlines Reasons for Regional Shareholders to Vote YES for Proposed Merger with SunLink Health Systems, Inc.
Written by Customer Service on . Posted in Public Companies.
First Central Savings Bank Reports Second Quarter 2025 Results Highlighted by Net Income of $1.6 million ($0.15 EPS), Net Interest Margin Expansion by 17 basis points on a linked quarter basis and Strong Non-Interest Income
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
H2O America Announces Second Quarter 2025 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
NOV Reports Second Quarter 2025 Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
GBank Financial Holdings Inc. Announces Second Quarter 2025 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Nano Dimension Statement Regarding Desktop Metal Bankruptcy and Strategic Decision Not to Acquire Assets
Written by Customer Service on . Posted in Public Companies.
FAT Brands to Announce Second Quarter 2025 Financial Results On July 30, 2025
Written by Customer Service on . Posted in Public Companies.
Brown & Brown, Inc. announces second quarter 2025 results, including total revenues of $1.3 billion, an increase of 9.1%; Organic Revenue growth of 3.6%; diluted net income per share of $0.78; and Diluted Net Income Per Share – Adjusted of $1.03
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
